Trial · NCT00423293
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Subjects With Acute Gastrointestinal (GI) and Genitourinary (GU) Adverse Events (AE) ≥ Grade 2 as Defined by CTCAE v3.0 (Common Terminology Criteria for Adverse Events) | From the start of treatment to 90 days | Eligible patients with adverse event information. | percentage of participants | NUMBER |
| SECONDARY | Number of Patients With Major Radiation Planning Deviations | Planning occurred prior to radiation therapy | All eligible patients who started IMRT | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Subjects With Acute Adverse Events (AE) | From the start of treatment to 90 days | Eligible patients who started protocol treatment | percentage of participants | NUMBER |
| SECONDARY | Percentage of Subjects With Late Adverse Events (AE) | From 91 days after start of study treatment to the end of follow-up. Maximum follow-up at time of analysis was 9.2 years. | Eligible patients who started IMRT and were on-study \> 90 days from the start of treatment (or did not withdraw consent until after 90 days). | percentage of participants | NUMBER |
| SECONDARY | Clinical Complete Response Rate | 8 and 12 weeks after treatment completion (corresponding to 14 and 18 weeks from registration) | Eligible patients who started study treatment | percentage of participants | NUMBER |
| SECONDARY | Duration of Radiotherapy Treatment | From start to end of radiation therapy (6 weeks) | Eligible patients who started IMRT | Days | MEDIAN |
| SECONDARY | Five-year Rate of Overall Survival | From registration to 5 years | Eligible patients who started study treatment | percentage of participants | NUMBER |
| SECONDARY | Five-year Rate of Disease-free Survival | From registration to 5 years | Eligible patients who started study treatment | percentage of participants | NUMBER |
| SECONDARY | Five-Year Cumulative Incidence Rate of Local-regional Failure | From registration to 5 years | Eligible patients who started study treatment | percentage of participants | NUMBER |
| SECONDARY | Five-Year Cumulative Incidence Rate of Distant Failure | From registration to 5 years | Eligible patients who started study treatment | percentage of participants | NUMBER |
| SECONDARY | Five-Year Cumulative Incidence Rate of Colostomy Failure | From registration to 5 years | Eligible patients who started study treatment | percentage of participants | NUMBER |
| SECONDARY | Five-Year Rate of Colostomy-free Survival | From registration to 5 years | Eligible patients who started study treatment | percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00423293/outcomes